0000950170-24-013414.txt : 20240209
0000950170-24-013414.hdr.sgml : 20240209
20240209180910
ACCESSION NUMBER: 0000950170-24-013414
CONFORMED SUBMISSION TYPE: 5
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231231
FILED AS OF DATE: 20240209
DATE AS OF CHANGE: 20240209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Xie Jian
CENTRAL INDEX KEY: 0001819718
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37894
FILM NUMBER: 24616679
MAIL ADDRESS:
STREET 1: C/O FULGENT GENETICS, INC.
STREET 2: 4399 SANTA ANITA AVE
CITY: EL MONTE
STATE: CA
ZIP: 91731
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fulgent Genetics, Inc.
CENTRAL INDEX KEY: 0001674930
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 812621304
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4399 SANTA ANITA AVE
CITY: EL MONTE
STATE: CA
ZIP: 91731
BUSINESS PHONE: 626-350-0537
MAIL ADDRESS:
STREET 1: 4399 SANTA ANITA AVE
CITY: EL MONTE
STATE: CA
ZIP: 91731
FORMER COMPANY:
FORMER CONFORMED NAME: Fulgent Diagnostics, Inc.
DATE OF NAME CHANGE: 20160517
5
1
ownership.xml
5
X0508
5
2023-12-31
0
1
0001674930
Fulgent Genetics, Inc.
FLGT
0001819718
Xie Jian
C/O FULGENT GENETICS, INC.
4399 SANTA ANITA AVENUE
EL MONTE
CA
91731
false
true
false
false
President and COO
false
Common Stock
2021-03-10
4
S
false
4300
108.2156
D
358824
D
Common Stock
2021-03-11
4
S
false
5700
101.6631
D
353124
D
Common Stock
220816
I
By Trust
The sale of the shares occured in the fiscal year ended December 31, 2021, but the filing of the Form 4 was inadvertently missed during that period.
The shares were sold in multiple transactions at prices ranging from $103.92 to $112.00, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission (the "SEC") staff, Fulgent Genetics, Inc. (the "Issuer") or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
The sale of the shares occured in the fiscal year ended December 31, 2021, but the filing of the Form 4 was inadvertently missed during that period.
The shares were sold in multiple transactions at prices ranging from $100.28 to $104.09, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Securities held by The Hsieh Family Dynasty Trust, dated January 27, 2010 (the "Trust"). Mr. Xie serves on the investment committee of the Trust. Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein.
/s/ Paul Kim as Attorney-in-Fact
2024-02-09